Quipt Home Medical Receives Conditional Approval to Graduate to the Toronto Stock Exchange Cincinnati, Ohio

Quipt Home Medical Receives Conditional Approval

to Graduate to the Toronto Stock Exchange

Cincinnati, Ohio - May 2, 2023 -

Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT; TSXV:QIPT), a U.S. based home

medical equipment provider, focused on end-to-end respiratory care, is very pleased to announce that it has received conditional approval

from the Toronto Stock Exchange ("TSX") to graduate its listing from the TSX Venture Exchange (the "TSXV")

"Graduating to the Toronto Stock Exchange

is a significant accomplishment, and I want to thank all our team members and shareholders for their ongoing support. Our ability to up-list

demonstrates the evolution of our organization through the years and the ongoing momentum across the business in real time as we strive

to become a national leader in respiratory care throughout the United States," said Greg Crawford, Chairman and CEO of Quipt. "This

up-listing is an important step towards improving liquidity and increasing our investor audience in North America and abroad. Given the

continued financial and operational success, this up-listing, and our effort to inform investors of our robust growth, have us extremely

optimistic about the future."

Final approval of the listing is subject to the

Company meeting certain customary conditions required by the TSX. The Company is working diligently to satisfy such listing conditions.

Further details and a timeline for graduation will be announced in due course. Upon satisfaction of the TSX listing conditions, Quipt's

common shares will be delisted from the TSXV.

Shareholders are not required to exchange their

share certificates or take any other action in connection with the TSX listing, as there will be no change in the trading symbol or CUSIP

for the common shares. The Company will continue to trade its common shares on the NASDAQ in the United States under the symbol "QIPT".

ABOUT QUIPT HOME MEDICAL CORP.

The Company provides in-home monitoring and disease

management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue

to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease,

sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder

value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's

organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the

patient's services, and making life easier for the patient.

Neither the TSX Venture Exchange nor its Regulation

Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or

accuracy of this release.

Certain statements contained in this press

release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation.

The words "may", "would", "could", "should", "potential", "will",

"seek", "intend", "plan", "anticipate", "believe", "estimate", "expect",

"outlook", and similar expressions as they relate to the Company, including: the Company satisfying TSX listing

conditions; the Company graduating to the TSX and the timing of graduation; and the anticipated results of an up-listing; are intended

to identify forward-looking information. All statements other than statements of historical fact may be forward- looking

information. Such statements reflect the Company's current views and intentions with respect to future events, and current

information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could

cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information

to vary from those described herein should one or more of these risks or uncertainties materialize. Examples of such risk

factors include, without limitation: risk related to credit, market (including equity, commodity, foreign exchange and

interest rate), liquidity, operational (including technology and infrastructure), reputational, insurance, strategic, regulatory,

legal, environmental, and capital adequacy; the general business and economic conditions in the regions in which the Company

operates; the ability of the Company to execute on key priorities, including the successful completion of acquisitions,

business retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly

acquired businesses; the ability to implement business strategies and pursue business opportunities; low profit market

segments; disruptions in or attacks (including cyber-attacks) on the Company's information technology, internet, network

access or other voice or data communications systems or services; the evolution of various types of fraud or other criminal

behavior to which the Company is exposed; the failure of third parties to comply with their obligations to the Company

or its affiliates; the impact of new and changes to, or application of, current laws and regulations; decline of reimbursement

rates; dependence on few payors; possible new drug discoveries; a novel business model; dependence on key suppliers; granting

of permits and licenses in a highly regulated business; the overall difficult litigation environment, including in the

U.S.; increased competition; changes in foreign currency rates; increased funding costs and market volatility due to market

illiquidity and competition for funding; the availability of funds and resources to pursue operations; critical accounting

estimates and changes to accounting standards, policies, and methods used by the Company; the occurrence of natural and

unnatural catastrophic events and claims resulting from such events; and risks related to COVID-19 including various recommendations,

orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions, border closures,

non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing, disruptions to

markets, economic activity, financing, supply chains and sales channels, and a deterioration of general economic conditions

including a possible national or global recession; as well as those risk factors discussed or referred to in the Company's

disclosure documents filed with United States Securities and Exchange Commission and available at www.sec.gov, and with

the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com. Should any factor

affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect,

the actual results or events may differ materially from the results or events predicted. Any such forward-looking information

is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility

for the accuracy or completeness of such forward-looking information. The forward-looking information included in this

press release is made as of the date of this press release and the Company undertakes no obligation to publicly update

or revise any forward-looking information, other than as required by applicable law .

For further information please visit our website at www.Quipthomemedical.com,

VP of Corporate Development

Quipt Home Medical Corp.

Chief Executive Officer

Quipt Home Medical Corp.